Ledent, Edouard http://orcid.org/0000-0003-3464-1247
Arlegui, Hugo
Buyse, Hubert
Basile, Peter
Karkada, Naveen
Praet, Nicolas
Nachbaur, Gaëlle
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
Article History
First Online: 27 March 2018
Compliance with Ethical Standards
:
: Edouard Ledent, Hugo Arlegui, Hubert Buyse, Naveen Karkada, Gaëlle Nachbaur and Nicolas Praet are employed by the GSK group of companies. Hubert Buyse, Edouard Ledent, Gaëlle Nachbaur and Nicolas Praet also hold shares in the GSK group of companies. Peter Basile was an employee of the GSK group of companies at the time of the study and also held shares in the GSK group of companies. Hugo Arlegui is also a doctoral fellow whose research is financed by the Association Nationale pour la Recherche et la Technologie (ANRT) (Paris, France) and the GSK group of companies.
: GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of study conduct and analysis. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and the publishing of the present manuscript.
: Rotarix is a trademark of the GSK group of companies. RotaTeq is a trademark of Merck & Co., Inc.